{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:51:47Z","timestamp":1792853507546,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.redox.2025.103528","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T02:20:10Z","timestamp":1738549210000},"page":"103528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis"],"prefix":"10.1016","volume":"80","author":[{"given":"Ning","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-fei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-kai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-8963","authenticated-orcid":false,"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2025.103528_bib1","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.redox.2025.103528_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.redox.2025.103528_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","article-title":"Tumor microenvironment: the culprit for ovarian cancer metastasis?","volume":"377","author":"Luo","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2025.103528_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174013","article-title":"Biology-driven therapy advances in high-grade serous ovarian cancer","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103528_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.redox.2025.103528_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","article-title":"NCCN Guidelines\u00ae insights: ovarian cancer, version 3.2022","volume":"20","author":"Armstrong","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.redox.2025.103528_bib7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.19.00022","article-title":"Role of neoadjuvant chemotherapy in advanced epithelial ovarian cancer","volume":"37","author":"du Bois","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2025.103528_bib8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.drudis.2020.04.015","article-title":"Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer","volume":"25","author":"Liu","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.redox.2025.103528_bib9","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","article-title":"Single-cell RNA sequencing reveals the tissue architecture in human high-grade serous ovarian cancer","volume":"28","author":"Xu","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103528_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cac2.12511","article-title":"Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer","volume":"44","author":"Raab","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.redox.2025.103528_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317095","article-title":"Homologous recombination deficiency (HRD) scoring, by means of two different shallow whole-genome sequencing pipelines (sWGS), in ovarian cancer patients: a comparison with myriad MyChoice assay","volume":"24","author":"Scaglione","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103528_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s10330-022-0557-7","article-title":"Recent advances in targeted therapy for ovarian cancer","volume":"8","author":"Qin","year":"2022","journal-title":"Oncol. Transl. Med."},{"key":"10.1016\/j.redox.2025.103528_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(19)30029-4","article-title":"Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial","volume":"20","author":"Moore","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.redox.2025.103528_bib14","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2025.103528_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.annonc.2020.12.018","article-title":"Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial","volume":"32","author":"Wu","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.redox.2025.103528_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamaoncol.2023.2283","article-title":"Treatment with niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer: a phase 3 randomized clinical trial","volume":"9","author":"Li","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.redox.2025.103528_bib17","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2025.103528_bib18","first-page":"619","article-title":"New therapies for ovarian cancer","volume":"17","author":"O'Malley","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.redox.2025.103528_bib19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40265-023-01934-0","article-title":"Treatment of ovarian cancer beyond PARP inhibition: current and future options","volume":"83","author":"Garg","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2025.103528_bib20","article-title":"Effectiveness and safety of niraparib as neoadjuvant therapy in advanced ovarian cancer with homologous recombination deficiency (NANT): study protocol for a prospective, multicenter, exploratory, phase 2, single-arm study","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.redox.2025.103528_bib21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103528_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2025.103528_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103528_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103528_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2023.11.017","article-title":"Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism","volume":"36","author":"Wedan","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103528_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103528_bib27","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1007\/s00432-023-04811-1","article-title":"Apatinib combined with olaparib induces ferroptosis via a p53-dependent manner in ovarian cancer","volume":"149","author":"Yue","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.redox.2025.103528_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","article-title":"Tumour fatty acid metabolism in the context of therapy resistance and obesity","volume":"21","author":"Hoy","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2025.103528_bib29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.redox.2025.103528_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MOL.0b013e3281338558","article-title":"Fatty acid transport proteins","volume":"18","author":"Gimeno","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.redox.2025.103528_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-60204-8_5","article-title":"Fatty acid oxidation in peroxisomes: enzymology, metabolic crosstalk with other organelles and peroxisomal disorders","volume":"1299","author":"Wanders","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.redox.2025.103528_bib32","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1093\/nar\/gkaa631","article-title":"NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest","volume":"48","author":"Sun","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2025.103528_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.RES.0000119171.44657.45","article-title":"Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal","volume":"94","author":"Ishii","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2025.103528_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.05.024","article-title":"Nrf2 activation: a potential strategy for the prevention of acute mountain sickness","volume":"63","author":"Lisk","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"18","key":"10.1016\/j.redox.2025.103528_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.redox.2025.103528_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119750","article-title":"Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition","volume":"280","author":"Balaji","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2025.103528_bib37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2025.103528_bib38","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2025.103528_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.01.012","article-title":"Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5","volume":"36","author":"Lai","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103528_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103528_bib41","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.redox.2025.103528_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/auto.5.1.7272","article-title":"PARP-1 is involved in autophagy induced by DNA damage","volume":"5","author":"Mu\u00f1oz-G\u00e1mez","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2025.103528_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s42003-022-03210-5","article-title":"Pre-activation of autophagy impacts response to olaparib in prostate cancer cells","volume":"5","author":"Cahuzac","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.redox.2025.103528_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2023.01.055","article-title":"PARP1 inhibitors induce pyroptosis via caspase 3-mediated gasdermin E cleavage","volume":"646","author":"Kim","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2025.103528_bib45","article-title":"Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103528_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009032","article-title":"PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD\/E axis in ovarian cancer","volume":"12","author":"Xia","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.redox.2025.103528_bib47","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41419-022-05257-y","article-title":"Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103528_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/imr.12533","article-title":"Ferroptosis: bug or feature?","volume":"277","author":"Dixon","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.redox.2025.103528_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","article-title":"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.redox.2025.103528_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104919","article-title":"The application of ferroptosis in diseases","volume":"159","author":"Qiu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2025.103528_bib51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2025.103528_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102006","article-title":"Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence","volume":"43","author":"Luis","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103528_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2025.103528_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.redox.2025.103528_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8 T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103528_bib56","article-title":"CD36 activity causes ferroptosis in tumor-infiltrating CD8+ T cells","volume":"11","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.redox.2025.103528_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104382","article-title":"Metabolism-dependent ferroptosis promotes mitochondrial dysfunction and inflammation in CD4+ T lymphocytes in HIV-infected immune non-responders","volume":"86","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.redox.2025.103528_bib58","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1111\/febs.16772","article-title":"Palmitic acid-induced ferroptosis via CD36 activates ER stress to break calcium-iron balance in colon cancer cells","volume":"290","author":"Kuang","year":"2023","journal-title":"FEBS J."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:40:22Z","timestamp":1741934422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"alternative-id":["S2213231725000412"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103528","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103528"}}